Bioceres Crop Solutions' Q1 revenue misses estimates
Bioceres Crop Solutions reported a 17% decline in fiscal Q1 revenue, missing analyst estimates of $90.23 million, with actual revenue at $77.50 million. However, adjusted EBITDA rose 61% to $13.60 million, surpassing expectations. The company is focusing on margin expansion, with gross margin increasing from 40% to 47%, and improving working capital efficiency. Analysts currently rate the stock as a "hold," with a median 12-month price target of $5.00, significantly above its recent closing price of $1.93.
)
Overview
- Bioceres fiscal Q1 revenue declines 17% yr/yr, missing analyst expectations
- Adjusted EBITDA for fiscal Q1 rises 61%, beating analyst expectations
- Company focuses on margin expansion and cost discipline amid revenue decline
Outlook
- Company prioritizes strengthening capital structure and financial flexibility
Result Drivers
- REVENUE DECLINE - Co attributes 17% revenue decline to strategic shift away from low-margin sales and timing issues in Latam markets
- MARGIN EXPANSION - Gross margin increased from 40% to 47% due to a more profitable product mix
- WORKING CAPITAL IMPROVEMENT - Co reports improved working capital efficiency despite seasonally high needs
Key Details
Metric Beat/Mis Actual Consensu
s s
Estimate
Q1 Miss $77.50 $90.23
Revenue mln mln (4
Analysts
)
Q1 Beat $13.60 $11.02
Adjusted mln mln (3
EBITDA Analysts
)
Analyst Coverage
- The current average analyst rating on the shares is “hold” and the breakdown of recommendations is 1 “strong buy” or “buy”, 3 “hold” and no “sell” or “strong sell”
- The average consensus recommendation for the agricultural chemicals peer group is “buy.”
- Wall Street’s median 12-month price target for Bioceres Crop Solutions Corp is $5.00, about 61.4% above its November 11 closing price of $1.93
Press Release: For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact . (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
